SCHEMBL10276046

SCHEMBL10276046

N#Cc1ccc(-c2cc(=O)n3nc(C4CC4)c(-c4ccc(F)cc4F)cc3n2)cc1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
AR P10275 1/20 0.41
PSD A5PKW4 3/20 0.40
KDM1A O60341 7/20 0.37
ARF6 P62330 2/20 0.36
KDM4E B2RXH2 1/20 0.35
MEN1 O00255 1/20 0.35
ALDH1A1 P00352 1/20 0.35
LMNA P02545 1/20 0.35
GLA P06280 1/20 0.35
POLB P06746 1/20 0.35
GAA P10253 1/20 0.35
MAPT P10636 1/20 0.35
KMT2A Q03164 1/20 0.35
L3MBTL1 Q9Y468 1/20 0.35
ADORA2A P29274 1/20 0.34
ADORA1 P30542 1/20 0.34
EGLN2 Q96KS0 1/20 0.34
PDE3B Q13370 1/20 0.34
PDE3A Q14432 1/20 0.34
RAD51 Q06609 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10275338 0.84 AR (0.43) ARPSDKDM4EMEN1ALDH1A1
SCHEMBL10275813 0.83 AR (0.42) ARPSDARF6KDM4EALDH1A1
SCHEMBL10275238 0.82 AR (0.41) ARPSDKDM1AKDM4EMEN1
SCHEMBL10275636 0.82 ADORA1 (0.43) ARKDM4EMEN1ALDH1A1LMNA
SCHEMBL10276133 0.79 AR (0.36) ARPSDKDM1AEGLN2PDE3B
SCHEMBL10276001 0.78 AR (0.38) ARPSDKDM4EALDH1A1MAPT
SCHEMBL10275663 0.75 ARF6 (0.47) ARPSDKDM1AARF6PDE3B
SCHEMBL10276164 0.74 ARF6 (0.41) ARKDM1AARF6EGLN2GABRG2
SCHEMBL10275985 0.73 MAPT (0.46) ARKDM4EMEN1ALDH1A1LMNA
SCHEMBL10275732 0.71 ALDH1A1 (0.43) KDM4EMEN1ALDH1A1LMNAPOLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-103554111-A Aromatic heterocyclic pyridine derivatives and analogs, and preparation method and application thereof LIAONING LIFENG SCIENCE AND TECHNOLOGY DEV CO LTD 2014-02-05 CN claimed
US-20120178915-A1 PYRIMIDINE DERIVATIVES AND ANALOGS, PREPARATION METHOD AND USE THEREOF XU LIFENG (US) 2012-07-12 US claimed
CN-103554111-A Aromatic heterocyclic pyridine derivatives and analogs, and preparation method and application thereof LIAONING LIFENG SCIENCE AND TECHNOLOGY DEV CO LTD 2014-02-05 CN disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120178915-A1 PYRIMIDINE DERIVATIVES AND ANALOGS, PREPARATION METHOD AND USE THEREOF TYMP, TYMS, ADORA3 AR 3221/4885PSD 591/4885KDM1A 3996/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.